Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Change in Accured Expenses (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Change in Accured Expenses for 4 consecutive years, with $772000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Change in Accured Expenses fell 42.81% year-over-year to $772000.0, compared with a TTM value of $2.7 million through Dec 2023, up 92.73%, and an annual FY2024 reading of $4.2 million, up 55.51% over the prior year.
  • Change in Accured Expenses was $772000.0 for Q4 2023 at Terns Pharmaceuticals, up from $6000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $2.7 million in Q1 2023 and bottomed at -$3.9 million in Q1 2021.
  • Average Change in Accured Expenses over 4 years is $347375.0, with a median of $398500.0 recorded in 2022.
  • The sharpest move saw Change in Accured Expenses crashed 700.0% in 2021, then surged 4766.67% in 2022.
  • Year by year, Change in Accured Expenses stood at -$77000.0 in 2020, then plummeted by 700.0% to -$616000.0 in 2021, then surged by 319.16% to $1.3 million in 2022, then plummeted by 42.81% to $772000.0 in 2023.
  • Business Quant data shows Change in Accured Expenses for TERN at $772000.0 in Q4 2023, $6000.0 in Q3 2023, and -$715000.0 in Q2 2023.